Article
It's a long way to the top (if you want to personalize immunotherapy).
Journal for immunotherapy of cancer - 1 Jan 2017
Haebe Sarah, Weigert Oliver
Abstract excerpt
Harnessing the immune system to attack tumor cells by targeting tumor-associated or -preferably- tumor-specific antigens has emerged as a promising but challenging treatment option for malignant lymphomas. Follicular lymphoma is among the most common lymphomas worldwide and remains incurable for most patients. Considered to be an immunogenic disease it represents an interesting disease entity for various...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
